Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1996
11/14/1996WO1996035438A1 Oncogene fusion protein peptide vaccines
11/14/1996WO1996027008A3 Agent for treating tumours and other hyperplasia
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/14/1996CA2218327A1 Pcna binding substance
11/14/1996CA2217860A1 Benzothiazoles and benzoxazoles, pharmaceutical compositions containing these compounds and their use and processes for preparing them
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0751778A4 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
11/13/1996EP0742203A2 Vitamin D compounds and method of preparing these compounds
11/13/1996EP0742015A1 Prodrugs for beta-lactamase and uses thereof
11/13/1996EP0741744A1 Immunogens against gonadotropin releasing hormone
11/13/1996EP0741729A1 Antitumour tetracyclic compounds
11/13/1996EP0741726A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/13/1996EP0741716A1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
11/13/1996EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0489850B1 New bis-platinum complexes as chemotherapeutic agents
11/13/1996CN1135756A Ganglioside GM3 analog Having sialic acid residue fluorinated at the 9-position and intermediate thereof
11/13/1996CN1135719A Estramustine formulations with improved pharmaceutical properties
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574156 N-carbonyl azetidin-2-ones
11/12/1996US5574137 Recombinant gamma interferons having enhanced stability and methods therefor
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/12/1996US5574039 Antitumor, fungicides
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996US5574024 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
11/12/1996US5574023 Stabilizes the helix conformation, amtitumor
11/12/1996US5574016 Anticoagulants and cardiovascular disorders
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996CA2017276C Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof
11/12/1996CA1338712C 3'-deamino-4'-deoxy-4'-amino anthracyclines
11/12/1996CA1338702C High drug:lipid formulations of liposomal- antineoplastic agents
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034867A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740581A1 Particulate material
11/06/1996EP0740552A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
11/06/1996EP0740551A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
11/06/1996EP0580642B1 Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
11/06/1996CN1033227C Method for prepn. of pyrimidine nucleoside derivatives having anti-tumor activity
11/05/1996US5571917 Taxoid intermediates
11/05/1996US5571914 Antitumor agents
11/05/1996US5571902 Synthesis of oligonucleotides
11/05/1996US5571900 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof
11/05/1996US5571845 Nitroaniline derivatives and their use as anti-tumour agents
11/05/1996US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
11/05/1996US5571835 Inhibitors of farnesyl-protein transferase
11/05/1996US5571818 Pyrrolyl-4h-pyranoisoquinolines
11/05/1996US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
11/05/1996US5571785 Antitumor agents; polymer-bound peptidyl anthracyclines
11/05/1996US5571711 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
11/05/1996US5571534 Drug formulations for parenteral use
11/05/1996US5571510 Method for selective methionine starvation of malignant cells in mammals
10/1996
10/31/1996WO1996034117A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033981A1 Quinazoline derivative
10/31/1996WO1996033980A1 Quinazoline derivatives
10/31/1996WO1996033979A1 Quinazoline derivatives
10/31/1996WO1996033978A1 Quinazoline derivative
10/31/1996WO1996033745A1 Formulations for lipophilic compounds
10/31/1996WO1996033739A1 Vaccines containing a saponin and a sterol
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033726A1 Preparation and use of sulfated oligosaccharides
10/31/1996WO1996033716A1 RARβ SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996033696A1 Novel collagen formulations
10/31/1996WO1996027663A3 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
1 ... 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 ... 2211